Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients

BACKGROUND: Shortening tuberculosis (TB) treatment duration is a research priority. This paper presents data from a prematurely terminated randomized clinical trial, of 4-month moxifloxacin or gatifloxacin regimens, in South India. METHODS: Newly diagnosed, sputum-positive HIV-negative pulmonary TB...

Descripción completa

Detalles Bibliográficos
Autores principales: Jawahar, Mohideen S., Banurekha, Vaithilingam V., Paramasivan, Chinnampedu N., Rahman, Fathima, Ramachandran, Rajeswari, Venkatesan, Perumal, Balasubramanian, Rani, Selvakumar, Nagamiah, Ponnuraja, Chinnaiyan, Iliayas, Allaudeen S., Gangadevi, Navaneethapandian P., Raman, Balambal, Baskaran, Dhanaraj, Kumar, Santhanakrishnan R., Kumar, Marimuthu M., Mohan, Victor, Ganapathy, Sudha, Kumar, Vanaja, Shanmugam, Geetha, Charles, Niruparani, Sakthivel, Murugesan R., Jagannath, Kannivelu, Chandrasekar, Chockalingam, Parthasarathy, Ramavaram T., Narayanan, Paranji R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700922/
https://www.ncbi.nlm.nih.gov/pubmed/23843980
http://dx.doi.org/10.1371/journal.pone.0067030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700922/
https://www.ncbi.nlm.nih.gov/pubmed/23843980
http://dx.doi.org/10.1371/journal.pone.0067030

Ejemplares similares